NeoGenomics (NEO) News Today $8.78 +0.06 (+0.69%) Closing price 04:00 PM EasternExtended Trading$8.63 -0.15 (-1.71%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period NeoGenomics, Inc. (NASDAQ:NEO) Short Interest UpdateNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 4,220,000 shares, an increase of 20.9% from the February 28th total of 3,490,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the short-interest ratio is currently 3.5 days. Currently, 3.3% of the shares of the stock are sold short.April 4 at 3:22 PM | marketbeat.comTesting & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)April 4 at 12:19 AM | finance.yahoo.comNeoGenomics CEO Chris Smith to depart, Tony Zook to succeedApril 2 at 12:41 PM | markets.businessinsider.comNeoGenomics announces CEO transitionApril 1 at 8:48 AM | msn.comNeoGenomics' New CEO Zook Takes Over as Smith RetiresApril 1 at 8:48 AM | marketwatch.comTony Zook Assumes Role as Chief Executive Officer of NeoGenomicsApril 1 at 7:05 AM | businesswire.comNeoGenomics (NEO) Gets a Hold from Benchmark Co.March 31, 2025 | markets.businessinsider.comLoomis Sayles & Co. L P Grows Position in NeoGenomics, Inc. (NASDAQ:NEO)Loomis Sayles & Co. L P lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 48.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,791,792 shares of the medical resMarch 29, 2025 | marketbeat.comAmerican Century Companies Inc. Sells 132,683 Shares of NeoGenomics, Inc. (NASDAQ:NEO)American Century Companies Inc. decreased its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,893,261 shares of the medical research company's stock after selling 132,68March 27, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $34.84 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Segall Bryant & Hamill LLC grew its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,113,822 shares of the medical research company's stock after buying an additiMarch 26, 2025 | marketbeat.comEmerald Advisers LLC Sells 124,777 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Emerald Advisers LLC decreased its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,557,437 shares of the medical research company's stocMarch 24, 2025 | marketbeat.com3 Reasons to Sell NEO and 1 Stock to Buy InsteadMarch 21, 2025 | msn.comEarnings call transcript: NeoGenomics Q4 2024 results disappoint despite EPS beatMarch 21, 2025 | uk.investing.comCharles Schwab Investment Management Inc. Grows Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)Charles Schwab Investment Management Inc. lifted its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,161,352 shares of the medical research compaMarch 20, 2025 | marketbeat.comNeoGenomics COO Melody Harris to depart, Warren Stone to succeedMarch 19, 2025 | markets.businessinsider.comNeoGenomics names Warren Stone as chief operating officerMarch 18, 2025 | msn.comBTIG Keeps Their Buy Rating on NeoGenomics (NEO)March 18, 2025 | markets.businessinsider.comNeoGenomics Appoints Warren Stone as President & Chief Operating OfficerMarch 18, 2025 | finance.yahoo.comNEO Battery Showcases Mass-Producible Silicon Battery Prototype with Highest Capacity Retention Achieved to DateMarch 18, 2025 | globenewswire.comRoyce & Associates LP Boosts Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Royce & Associates LP grew its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 5.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 675,866 shares of the medical research companMarch 18, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Shares Down 7% - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Down 7% - Should You Sell?March 13, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Trading 7.2% Higher - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Up 7.2% - Should You Buy?March 12, 2025 | marketbeat.comTD Cowen Sticks to Its Buy Rating for NeoGenomics (NEO)March 11, 2025 | markets.businessinsider.comNeoGenomics acquires Pathline, terms undisclosedMarch 10, 2025 | markets.businessinsider.comNeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of PathlineMarch 10, 2025 | finance.yahoo.comNeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by BrokeragesNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has been given an average rating of "Moderate Buy" by the ten ratings firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The aMarch 10, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Releases FY 2025 Earnings GuidanceNeoGenomics (NASDAQ:NEO) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.150-0.190 for the period, compared to the consensus estimate of 0.200. The company also issued revenue guidance of $735.0 millionillion-$745.0 millionillion, compared to the consensus estimate of $735.0 millionillion.March 7, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Sets New 1-Year Low - Here's What HappenedNeoGenomics (NASDAQ:NEO) Hits New 12-Month Low - Here's WhyMarch 4, 2025 | marketbeat.comNeoGenomics: Decent Fundamentals, But Still OvervaluedFebruary 28, 2025 | seekingalpha.comPiper Sandler Has Lowered Expectations for NeoGenomics (NASDAQ:NEO) Stock PricePiper Sandler lowered their price objective on shares of NeoGenomics from $21.00 to $18.00 and set an "overweight" rating on the stock in a research note on Wednesday.February 27, 2025 | marketbeat.comPiper Sandler Remains a Buy on NeoGenomics (NEO)February 26, 2025 | markets.businessinsider.comNeoGenomics price target lowered to $18 from $21 at Piper SandlerFebruary 26, 2025 | markets.businessinsider.comBTIG Sticks to Their Buy Rating for NeoGenomics (NEO)February 25, 2025 | markets.businessinsider.comNeoGenomics (NASDAQ:NEO) Reaches New 52-Week Low - Here's What HappenedNeoGenomics (NASDAQ:NEO) Reaches New 1-Year Low - Here's What HappenedFebruary 25, 2025 | marketbeat.comNeoGenomics to Participate in Upcoming Investor ConferencesFebruary 24, 2025 | businesswire.comQ1 Earnings Forecast for NeoGenomics Issued By William BlairNeoGenomics, Inc. (NASDAQ:NEO - Free Report) - Analysts at William Blair issued their Q1 2026 earnings per share estimates for shares of NeoGenomics in a research note issued to investors on Tuesday, February 18th. William Blair analyst A. Brackmann anticipates that the medical research company wFebruary 22, 2025 | marketbeat.comQ3 EPS Estimates for NeoGenomics Raised by Leerink PartnrsNeoGenomics, Inc. (NASDAQ:NEO - Free Report) - Equities researchers at Leerink Partnrs boosted their Q3 2025 earnings per share (EPS) estimates for shares of NeoGenomics in a report released on Tuesday, February 18th. Leerink Partnrs analyst P. Souda now anticipates that the medical research compFebruary 22, 2025 | marketbeat.comBank of America Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock PriceBank of America decreased their price target on NeoGenomics from $19.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday.February 20, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Price Target Cut to $18.00 by Analysts at Needham & Company LLCNeedham & Company LLC dropped their target price on NeoGenomics from $19.00 to $18.00 and set a "buy" rating on the stock in a report on Wednesday.February 20, 2025 | marketbeat.comNeoGenomics price target lowered to $17 from $18 at BTIGFebruary 20, 2025 | markets.businessinsider.comNeoGenomics price target lowered to $16 from $19 at BofAFebruary 20, 2025 | markets.businessinsider.comFort Myers-based NeoGenomics reports mixed results for the fourth quarterFebruary 20, 2025 | msn.comNeoGenomics price target lowered to $19 from $20 at TD CowenFebruary 19, 2025 | markets.businessinsider.comNeoGenomics (NASDAQ:NEO) Sets New 52-Week Low After Earnings MissNeoGenomics (NASDAQ:NEO) Hits New 52-Week Low After Earnings MissFebruary 19, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Q4 2024 Earnings Call TranscriptFebruary 19, 2025 | insidermonkey.comNeoGenomics (NASDAQ:NEO) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPSNeoGenomics (NASDAQ:NEO - Get Free Report) issued its quarterly earnings data on Tuesday. The medical research company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.05). NeoGenomics had a negative return on equity of 2.11% and a negative net margin of 12.07%.February 19, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Issues Earnings ResultsNeoGenomics (NASDAQ:NEO - Get Free Report) announced its quarterly earnings data on Tuesday. The medical research company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by ($0.05). NeoGenomics had a negative net margin of 12.07% and a negative return on equity of 2.11%.February 19, 2025 | marketbeat.comNeoGenomics stock tumbles on weak EPS guidanceFebruary 19, 2025 | investing.comNeoGenomics reports Q4 adjusted EPS 4c, consensus 3cFebruary 19, 2025 | markets.businessinsider.comNeoGenomics Shares Decline on Forecast for Wider-Than-Expected Loss in 2025February 19, 2025 | marketwatch.com Remove Ads Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address NEO Media Mentions By Week NEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼0.160.61▲Average Medical News Sentiment NEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼94▲NEO Articles Average Week Remove Ads Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amentum News Remitly Global News MARA News TriNet Group News Concentrix News Autohome News StoneCo News Alight News DXC Technology News CarGurus News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NEO Stock Free NEO Stock Alerts